KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to $131.9 million.

  • Exact Sciences' Net Cash Flow rose 132.38% to $131.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $197.2 million, marking a year-over-year increase of 7639.22%. This contributed to the annual value of $255,000 for FY2024, which is 99.93% down from last year.
  • Per Exact Sciences' latest filing, its Net Cash Flow stood at $131.9 million for Q3 2025, which was down 57.36% from $309.4 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Net Cash Flow registered a high of $309.4 million during Q2 2025, and its lowest value of -$740.1 million during Q2 2021.
  • For the 3-year period, Exact Sciences' Net Cash Flow averaged around $49.8 million, with its median value being $56.8 million (2024).
  • As far as peak fluctuations go, Exact Sciences' Net Cash Flow crashed by 25,851.15% in 2021, and later spiked by 766.71% in 2024.
  • Over the past 5 years, Exact Sciences' Net Cash Flow (Quarterly) stood at $41.7 million in 2021, then plummeted by 90.45% to $4.0 million in 2022, then skyrocketed by 222.00% to $12.8 million in 2023, then climbed by 22.40% to $15.7 million in 2024, then surged by 132.38% to $131.9 million in 2025.
  • Its last three reported values are $131.9 million in Q3 2025, $309.4 million for Q2 2025, and -$259.8 million during Q1 2025.